| Thomas E Dunaway, MD | |
|
535 E Main St Ste A, Lander, WY 82520-3424 | |
| (307) 335-7720 | |
| (307) 335-7723 |
| Full Name | Thomas E Dunaway |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 46 Years |
| Location | 535 E Main St Ste A, Lander, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457454837 | NPI | - | NPPES |
| 129852600 | Medicaid | WY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35042438D (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lander Womens Care Llc | 3375779838 | 3 |
News Archive
Philanthropist Steve Tisch, co-owner of the New York Giants and an Academy Award-winning film producer, has pledged $10 million to the department of neurosurgery at the David Geffen School of Medicine at UCLA for the BrainSPORT Program, which has been renamed the UCLA Steve Tisch BrainSPORT Program.
Bedfont presents its new Hydrogen and Methane Breath Testing Home Kits in association with GI Cognition.
Watson Pharmaceuticals, Inc. announced today that, under a settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis International Pharmaceutical Ltd., and Proterra AG (collectively "Novartis"), Watson has commenced shipment of a generic version of Exelon® (rivastigmine tartrate) 1.5mg, 3mg, 4.5mg and 6mg capsules. Exelon® is used to treat dementia in people with Alzheimer's disease.
Toxcure, LLC, an emerging specialty biopharmaceutical company, today announced the grant of U.S. Patent No. 7,709,440, which provides Toxcure with intellectual property protection for a method of treating various tumors with neurotoxins.
George Washington University researchers have found that topically applied nitric oxide-releasing nanoparticles (NO-np) are a viable treatment for deep fungal infections of the skin caused by dermatophytes, for which the current standard of care is treatment with systemic antifungals.
› Verified 9 days ago
| Entity Name | Lander Womens Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932547171 PECOS PAC ID: 3375779838 Enrollment ID: O20131112000944 |
News Archive
Philanthropist Steve Tisch, co-owner of the New York Giants and an Academy Award-winning film producer, has pledged $10 million to the department of neurosurgery at the David Geffen School of Medicine at UCLA for the BrainSPORT Program, which has been renamed the UCLA Steve Tisch BrainSPORT Program.
Bedfont presents its new Hydrogen and Methane Breath Testing Home Kits in association with GI Cognition.
Watson Pharmaceuticals, Inc. announced today that, under a settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis International Pharmaceutical Ltd., and Proterra AG (collectively "Novartis"), Watson has commenced shipment of a generic version of Exelon® (rivastigmine tartrate) 1.5mg, 3mg, 4.5mg and 6mg capsules. Exelon® is used to treat dementia in people with Alzheimer's disease.
Toxcure, LLC, an emerging specialty biopharmaceutical company, today announced the grant of U.S. Patent No. 7,709,440, which provides Toxcure with intellectual property protection for a method of treating various tumors with neurotoxins.
George Washington University researchers have found that topically applied nitric oxide-releasing nanoparticles (NO-np) are a viable treatment for deep fungal infections of the skin caused by dermatophytes, for which the current standard of care is treatment with systemic antifungals.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas E Dunaway, MD 535 E Main St Ste A, Lander, WY 82520-3424 Ph: (307) 335-7720 | Thomas E Dunaway, MD 535 E Main St Ste A, Lander, WY 82520-3424 Ph: (307) 335-7720 |
News Archive
Philanthropist Steve Tisch, co-owner of the New York Giants and an Academy Award-winning film producer, has pledged $10 million to the department of neurosurgery at the David Geffen School of Medicine at UCLA for the BrainSPORT Program, which has been renamed the UCLA Steve Tisch BrainSPORT Program.
Bedfont presents its new Hydrogen and Methane Breath Testing Home Kits in association with GI Cognition.
Watson Pharmaceuticals, Inc. announced today that, under a settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis International Pharmaceutical Ltd., and Proterra AG (collectively "Novartis"), Watson has commenced shipment of a generic version of Exelon® (rivastigmine tartrate) 1.5mg, 3mg, 4.5mg and 6mg capsules. Exelon® is used to treat dementia in people with Alzheimer's disease.
Toxcure, LLC, an emerging specialty biopharmaceutical company, today announced the grant of U.S. Patent No. 7,709,440, which provides Toxcure with intellectual property protection for a method of treating various tumors with neurotoxins.
George Washington University researchers have found that topically applied nitric oxide-releasing nanoparticles (NO-np) are a viable treatment for deep fungal infections of the skin caused by dermatophytes, for which the current standard of care is treatment with systemic antifungals.
› Verified 9 days ago
Dr. Ken V Holt, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 125 Wyoming St, Lander, WY 82520 Phone: 307-206-1330 Fax: 307-206-1331 | |
Dr. James Clayton Brubaker, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 745 Buena Vista Dr, Lander, WY 82520 Phone: 307-332-2941 Fax: 307-332-2068 | |
Dr. Karla Lee Wagner, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 745 Buena Vista Dr, Lander, WY 82520 Phone: 307-332-2941 Fax: 307-332-2068 | |
Jan K. Siebersma, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 745 Buena Vista Dr, Lander, WY 82520 Phone: 307-332-2941 Fax: 307-332-1920 |